Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 450Stomach Neoplasms 295Rectal Neoplasms 271Colonic Neoplasms 192Pancreatic Neoplasms 177Neoplasm Metastasis 94Esophageal Neoplasms 88Carcinoma, Hepatocellular 60Adenocarcinoma Of Esophagus 47Cholangiocarcinoma 46Neoplasms 42Biliary Tract Neoplasms 38Gallbladder Neoplasms 31Adenocarcinoma 30Gastrointestinal Neoplasms 29Liver Neoplasms 25Esophageal Squamous Cell Carcinoma 23Carcinoma, Non-Small-Cell Lung 18Bile Duct Neoplasms 17Parkinson Disease 4, Autosomal Dominant Lewy Body 13Locally Advanced Rectal Cancer 13Colorectal Cancer Metastatic 11Appendiceal Neoplasms 11Recurrence 10Peritoneal Neoplasms 10Ovarian Neoplasms 9Carcinoma 7Breast Neoplasms 7Neurotoxicity Syndromes 6Gastrointestinal Diseases 6

Interventions

zolbetuximab 1trifluridine tipiracil drug combination 1tipiracil 1camrelizumab 1Trifluridine 1Taxes 1Oxaliplatin 1HMPL-013 1Docetaxel 1Cetuximab 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastric Cancer Adenocarcinoma Metastatic × Oxaliplatin × Gastrointestinal × Clear all
NCT00517829 2016-11-28

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

US Oncology Research

Phase 2 Completed
150 enrolled 12 charts
Gastrointestinal

Gastric Cancer Adenocarcinoma Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡